Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells

Background/Aims: The Warburg effect is one of the main metabolic features for cancers, with long non-coding RNA (lncRNA) being involved as a class of crucial regulators. Our previous studies have shown that ginsenoside 20(S)-Rg3, an active saponin monomer extracted from red ginseng, inhibits the War...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cellular physiology and biochemistry 2018-01, Vol.51 (3), p.1340-1353
Hauptverfasser: Zheng, Xia, Zhou, Yuanyuan, Chen, Wei, Chen, Lihong, Lu, Jiaojiao, He, Fang, Li, Xu, Zhao, Le
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1353
container_issue 3
container_start_page 1340
container_title Cellular physiology and biochemistry
container_volume 51
creator Zheng, Xia
Zhou, Yuanyuan
Chen, Wei
Chen, Lihong
Lu, Jiaojiao
He, Fang
Li, Xu
Zhao, Le
description Background/Aims: The Warburg effect is one of the main metabolic features for cancers, with long non-coding RNA (lncRNA) being involved as a class of crucial regulators. Our previous studies have shown that ginsenoside 20(S)-Rg3, an active saponin monomer extracted from red ginseng, inhibits the Warburg effect in ovarian cancer cells. However, the detailed lncRNA regulatory network modulated by 20(S)-Rg3 to prevent the Warburg effect in ovarian cancer cells has not been explored. Methods: High-throughput sequencing was used to screen out the differentially expressed lncRNAs between 20(S)-Rg3-treated and non-treated SKOV3 cells. The levels of lncRNA H19 and miR-324-5p were manipulated in SKOV3 and A2780, and the glucose consumption, lactate production and PKM2 protein level were detected. Dual-luciferase reporter assay and RIP were utilized to verify the direct binding of H19 to miR-324-5p and miR-324-5p to PKM2. Cell proliferation was examined by CCK8 and colony formation assay. Nude mice subcutaneous xenograft tumor models were established to evaluate the impact of miR-324-5p on tumor growth in vivo. Results: 20(S)-Rg3 downregulated 67 lncRNAs, and H19 was one of the most decreased lncRNAs. Suppression of H19 by siRNA transfection reduced glucose consumption, lactate production and PKM2 expression in ovarian cancer cells, while H19 overexpression in 20(S)-Rg3-treated ovarian cancer cells enhanced glucose consumption, lactate production and PKM2 expression. Dual-luciferase reporter assay and RIP results showed that H19 directly bound to miR-324-5p. Dual-luciferase reporter assay showed that miR-324-5p directly targeted PKM2, and miR-324-5p negatively regulated glucose consumption and lactate production in ovarian cancer cells. miR-324-5p overexpression inhibited cell proliferation in vitro and in vivo. Conclusion: Our study revealed that 20(S)-Rg3 blocked the competitive inhibition of H19 on miR-324-5p, which enhanced the suppression of miR-324-5p on PKM2 and therefore inhibited the Warburg effect and repressed tumorigenesis. In a word, 20(S)-Rg3 inhibited the Warburg effect in ovarian cancer cells via H19/miR-324-5p/PKM2 pathway.
doi_str_mv 10.1159/000495552
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_30481782</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c8b7dddb2feb4f43956b946ae52568ba</doaj_id><sourcerecordid>2301910543</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-5664025015458f9cb9dec288a4d8f175ac1469add495c5ecc7539397f40333383</originalsourceid><addsrcrecordid>eNptkTtvFDEUhUeIiIRAQY-QJRpSDPg5Y5dhlJcSlFUSRGl5_Bi87NoTezZSaPnj8WaXpcGNfX0_nWPfU1XvEPyMEBNfIIRUMMbwi-oAUYxq0bb8ZTlDxGoueLtfvc55DkvZCvyq2ieQctRyfFD9OfMh2xCzNxZg-On2qL4ZCJgl-2DDlMHs8huu71Qa7OTDAJb-piaY1mwELsUlOEcC3I4xDOvmFMFxmNQQg_9twfTTgh8q9as0gBPnrJ6AD-D6QSWvAuhU0DaBzi4W-U2159Qi27fb_bD6fnpy153XV9dnF93xVa1pQ6aaNQ2FmJVPUMad0L0wVmPOFTXcoZYpjWgjlDFlFppZrVtGBBGto5CUxclhdbHRNVHN5Zj8UqVHGZWXzxcxDVKlyeuFlZr3rTGmx8721FEiWNML2ijLMGt4r4rWx43WmOL9yuZJzuMqhfJ8iQlEAkFGSaGONpROMedk3c4VQbmOTu6iK-yHreKqX1qzI_9m9c_y1zqOtAO62deNhByNK9T7_1Jblye9U6Sb</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2301910543</pqid></control><display><type>article</type><title>Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Karger Open Access</source><creator>Zheng, Xia ; Zhou, Yuanyuan ; Chen, Wei ; Chen, Lihong ; Lu, Jiaojiao ; He, Fang ; Li, Xu ; Zhao, Le</creator><creatorcontrib>Zheng, Xia ; Zhou, Yuanyuan ; Chen, Wei ; Chen, Lihong ; Lu, Jiaojiao ; He, Fang ; Li, Xu ; Zhao, Le</creatorcontrib><description>Background/Aims: The Warburg effect is one of the main metabolic features for cancers, with long non-coding RNA (lncRNA) being involved as a class of crucial regulators. Our previous studies have shown that ginsenoside 20(S)-Rg3, an active saponin monomer extracted from red ginseng, inhibits the Warburg effect in ovarian cancer cells. However, the detailed lncRNA regulatory network modulated by 20(S)-Rg3 to prevent the Warburg effect in ovarian cancer cells has not been explored. Methods: High-throughput sequencing was used to screen out the differentially expressed lncRNAs between 20(S)-Rg3-treated and non-treated SKOV3 cells. The levels of lncRNA H19 and miR-324-5p were manipulated in SKOV3 and A2780, and the glucose consumption, lactate production and PKM2 protein level were detected. Dual-luciferase reporter assay and RIP were utilized to verify the direct binding of H19 to miR-324-5p and miR-324-5p to PKM2. Cell proliferation was examined by CCK8 and colony formation assay. Nude mice subcutaneous xenograft tumor models were established to evaluate the impact of miR-324-5p on tumor growth in vivo. Results: 20(S)-Rg3 downregulated 67 lncRNAs, and H19 was one of the most decreased lncRNAs. Suppression of H19 by siRNA transfection reduced glucose consumption, lactate production and PKM2 expression in ovarian cancer cells, while H19 overexpression in 20(S)-Rg3-treated ovarian cancer cells enhanced glucose consumption, lactate production and PKM2 expression. Dual-luciferase reporter assay and RIP results showed that H19 directly bound to miR-324-5p. Dual-luciferase reporter assay showed that miR-324-5p directly targeted PKM2, and miR-324-5p negatively regulated glucose consumption and lactate production in ovarian cancer cells. miR-324-5p overexpression inhibited cell proliferation in vitro and in vivo. Conclusion: Our study revealed that 20(S)-Rg3 blocked the competitive inhibition of H19 on miR-324-5p, which enhanced the suppression of miR-324-5p on PKM2 and therefore inhibited the Warburg effect and repressed tumorigenesis. In a word, 20(S)-Rg3 inhibited the Warburg effect in ovarian cancer cells via H19/miR-324-5p/PKM2 pathway.</description><identifier>ISSN: 1015-8987</identifier><identifier>EISSN: 1421-9778</identifier><identifier>DOI: 10.1159/000495552</identifier><identifier>PMID: 30481782</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Animals ; Antineoplastic Agents, Phytogenic - pharmacology ; Antineoplastic Agents, Phytogenic - therapeutic use ; Apoptosis ; Bioinformatics ; Breast cancer ; Cancer therapies ; Carrier Proteins - genetics ; Cell culture ; Cell growth ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Female ; Gene expression ; Gene Expression Regulation, Neoplastic - drug effects ; Ginsenoside ; Ginsenosides - pharmacology ; Ginsenosides - therapeutic use ; Glycolysis - drug effects ; Humans ; Immunoglobulins ; Kinases ; Long non-coding RNA ; Medical prognosis ; Membrane Proteins - genetics ; Metabolism ; Metastasis ; Mice, Inbred BALB C ; MicroRNAs ; MicroRNAs - genetics ; Original Paper ; Ovarian cancer ; Ovarian Neoplasms - drug therapy ; Ovarian Neoplasms - genetics ; Ovarian Neoplasms - metabolism ; Ovarian Neoplasms - pathology ; Ovary - drug effects ; Ovary - metabolism ; Ovary - pathology ; Proteins ; RNA, Long Noncoding - genetics ; Thyroid Hormone-Binding Proteins ; Thyroid Hormones - genetics ; Warburg effect</subject><ispartof>Cellular physiology and biochemistry, 2018-01, Vol.51 (3), p.1340-1353</ispartof><rights>2018 The Author(s). Published by S. Karger AG, Basel</rights><rights>2018 The Author(s). Published by S. Karger AG, Basel.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-5664025015458f9cb9dec288a4d8f175ac1469add495c5ecc7539397f40333383</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,865,2103,27640,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30481782$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zheng, Xia</creatorcontrib><creatorcontrib>Zhou, Yuanyuan</creatorcontrib><creatorcontrib>Chen, Wei</creatorcontrib><creatorcontrib>Chen, Lihong</creatorcontrib><creatorcontrib>Lu, Jiaojiao</creatorcontrib><creatorcontrib>He, Fang</creatorcontrib><creatorcontrib>Li, Xu</creatorcontrib><creatorcontrib>Zhao, Le</creatorcontrib><title>Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells</title><title>Cellular physiology and biochemistry</title><addtitle>Cell Physiol Biochem</addtitle><description>Background/Aims: The Warburg effect is one of the main metabolic features for cancers, with long non-coding RNA (lncRNA) being involved as a class of crucial regulators. Our previous studies have shown that ginsenoside 20(S)-Rg3, an active saponin monomer extracted from red ginseng, inhibits the Warburg effect in ovarian cancer cells. However, the detailed lncRNA regulatory network modulated by 20(S)-Rg3 to prevent the Warburg effect in ovarian cancer cells has not been explored. Methods: High-throughput sequencing was used to screen out the differentially expressed lncRNAs between 20(S)-Rg3-treated and non-treated SKOV3 cells. The levels of lncRNA H19 and miR-324-5p were manipulated in SKOV3 and A2780, and the glucose consumption, lactate production and PKM2 protein level were detected. Dual-luciferase reporter assay and RIP were utilized to verify the direct binding of H19 to miR-324-5p and miR-324-5p to PKM2. Cell proliferation was examined by CCK8 and colony formation assay. Nude mice subcutaneous xenograft tumor models were established to evaluate the impact of miR-324-5p on tumor growth in vivo. Results: 20(S)-Rg3 downregulated 67 lncRNAs, and H19 was one of the most decreased lncRNAs. Suppression of H19 by siRNA transfection reduced glucose consumption, lactate production and PKM2 expression in ovarian cancer cells, while H19 overexpression in 20(S)-Rg3-treated ovarian cancer cells enhanced glucose consumption, lactate production and PKM2 expression. Dual-luciferase reporter assay and RIP results showed that H19 directly bound to miR-324-5p. Dual-luciferase reporter assay showed that miR-324-5p directly targeted PKM2, and miR-324-5p negatively regulated glucose consumption and lactate production in ovarian cancer cells. miR-324-5p overexpression inhibited cell proliferation in vitro and in vivo. Conclusion: Our study revealed that 20(S)-Rg3 blocked the competitive inhibition of H19 on miR-324-5p, which enhanced the suppression of miR-324-5p on PKM2 and therefore inhibited the Warburg effect and repressed tumorigenesis. In a word, 20(S)-Rg3 inhibited the Warburg effect in ovarian cancer cells via H19/miR-324-5p/PKM2 pathway.</description><subject>Animals</subject><subject>Antineoplastic Agents, Phytogenic - pharmacology</subject><subject>Antineoplastic Agents, Phytogenic - therapeutic use</subject><subject>Apoptosis</subject><subject>Bioinformatics</subject><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Carrier Proteins - genetics</subject><subject>Cell culture</subject><subject>Cell growth</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Female</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>Ginsenoside</subject><subject>Ginsenosides - pharmacology</subject><subject>Ginsenosides - therapeutic use</subject><subject>Glycolysis - drug effects</subject><subject>Humans</subject><subject>Immunoglobulins</subject><subject>Kinases</subject><subject>Long non-coding RNA</subject><subject>Medical prognosis</subject><subject>Membrane Proteins - genetics</subject><subject>Metabolism</subject><subject>Metastasis</subject><subject>Mice, Inbred BALB C</subject><subject>MicroRNAs</subject><subject>MicroRNAs - genetics</subject><subject>Original Paper</subject><subject>Ovarian cancer</subject><subject>Ovarian Neoplasms - drug therapy</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Ovarian Neoplasms - metabolism</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Ovary - drug effects</subject><subject>Ovary - metabolism</subject><subject>Ovary - pathology</subject><subject>Proteins</subject><subject>RNA, Long Noncoding - genetics</subject><subject>Thyroid Hormone-Binding Proteins</subject><subject>Thyroid Hormones - genetics</subject><subject>Warburg effect</subject><issn>1015-8987</issn><issn>1421-9778</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DOA</sourceid><recordid>eNptkTtvFDEUhUeIiIRAQY-QJRpSDPg5Y5dhlJcSlFUSRGl5_Bi87NoTezZSaPnj8WaXpcGNfX0_nWPfU1XvEPyMEBNfIIRUMMbwi-oAUYxq0bb8ZTlDxGoueLtfvc55DkvZCvyq2ieQctRyfFD9OfMh2xCzNxZg-On2qL4ZCJgl-2DDlMHs8huu71Qa7OTDAJb-piaY1mwELsUlOEcC3I4xDOvmFMFxmNQQg_9twfTTgh8q9as0gBPnrJ6AD-D6QSWvAuhU0DaBzi4W-U2159Qi27fb_bD6fnpy153XV9dnF93xVa1pQ6aaNQ2FmJVPUMad0L0wVmPOFTXcoZYpjWgjlDFlFppZrVtGBBGto5CUxclhdbHRNVHN5Zj8UqVHGZWXzxcxDVKlyeuFlZr3rTGmx8721FEiWNML2ijLMGt4r4rWx43WmOL9yuZJzuMqhfJ8iQlEAkFGSaGONpROMedk3c4VQbmOTu6iK-yHreKqX1qzI_9m9c_y1zqOtAO62deNhByNK9T7_1Jblye9U6Sb</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Zheng, Xia</creator><creator>Zhou, Yuanyuan</creator><creator>Chen, Wei</creator><creator>Chen, Lihong</creator><creator>Lu, Jiaojiao</creator><creator>He, Fang</creator><creator>Li, Xu</creator><creator>Zhao, Le</creator><general>S. Karger AG</general><general>Cell Physiol Biochem Press GmbH &amp; Co KG</general><scope>M--</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>DOA</scope></search><sort><creationdate>20180101</creationdate><title>Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells</title><author>Zheng, Xia ; Zhou, Yuanyuan ; Chen, Wei ; Chen, Lihong ; Lu, Jiaojiao ; He, Fang ; Li, Xu ; Zhao, Le</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-5664025015458f9cb9dec288a4d8f175ac1469add495c5ecc7539397f40333383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Antineoplastic Agents, Phytogenic - pharmacology</topic><topic>Antineoplastic Agents, Phytogenic - therapeutic use</topic><topic>Apoptosis</topic><topic>Bioinformatics</topic><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Carrier Proteins - genetics</topic><topic>Cell culture</topic><topic>Cell growth</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Female</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>Ginsenoside</topic><topic>Ginsenosides - pharmacology</topic><topic>Ginsenosides - therapeutic use</topic><topic>Glycolysis - drug effects</topic><topic>Humans</topic><topic>Immunoglobulins</topic><topic>Kinases</topic><topic>Long non-coding RNA</topic><topic>Medical prognosis</topic><topic>Membrane Proteins - genetics</topic><topic>Metabolism</topic><topic>Metastasis</topic><topic>Mice, Inbred BALB C</topic><topic>MicroRNAs</topic><topic>MicroRNAs - genetics</topic><topic>Original Paper</topic><topic>Ovarian cancer</topic><topic>Ovarian Neoplasms - drug therapy</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Ovarian Neoplasms - metabolism</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Ovary - drug effects</topic><topic>Ovary - metabolism</topic><topic>Ovary - pathology</topic><topic>Proteins</topic><topic>RNA, Long Noncoding - genetics</topic><topic>Thyroid Hormone-Binding Proteins</topic><topic>Thyroid Hormones - genetics</topic><topic>Warburg effect</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheng, Xia</creatorcontrib><creatorcontrib>Zhou, Yuanyuan</creatorcontrib><creatorcontrib>Chen, Wei</creatorcontrib><creatorcontrib>Chen, Lihong</creatorcontrib><creatorcontrib>Lu, Jiaojiao</creatorcontrib><creatorcontrib>He, Fang</creatorcontrib><creatorcontrib>Li, Xu</creatorcontrib><creatorcontrib>Zhao, Le</creatorcontrib><collection>Karger Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cellular physiology and biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zheng, Xia</au><au>Zhou, Yuanyuan</au><au>Chen, Wei</au><au>Chen, Lihong</au><au>Lu, Jiaojiao</au><au>He, Fang</au><au>Li, Xu</au><au>Zhao, Le</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells</atitle><jtitle>Cellular physiology and biochemistry</jtitle><addtitle>Cell Physiol Biochem</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>51</volume><issue>3</issue><spage>1340</spage><epage>1353</epage><pages>1340-1353</pages><issn>1015-8987</issn><eissn>1421-9778</eissn><abstract>Background/Aims: The Warburg effect is one of the main metabolic features for cancers, with long non-coding RNA (lncRNA) being involved as a class of crucial regulators. Our previous studies have shown that ginsenoside 20(S)-Rg3, an active saponin monomer extracted from red ginseng, inhibits the Warburg effect in ovarian cancer cells. However, the detailed lncRNA regulatory network modulated by 20(S)-Rg3 to prevent the Warburg effect in ovarian cancer cells has not been explored. Methods: High-throughput sequencing was used to screen out the differentially expressed lncRNAs between 20(S)-Rg3-treated and non-treated SKOV3 cells. The levels of lncRNA H19 and miR-324-5p were manipulated in SKOV3 and A2780, and the glucose consumption, lactate production and PKM2 protein level were detected. Dual-luciferase reporter assay and RIP were utilized to verify the direct binding of H19 to miR-324-5p and miR-324-5p to PKM2. Cell proliferation was examined by CCK8 and colony formation assay. Nude mice subcutaneous xenograft tumor models were established to evaluate the impact of miR-324-5p on tumor growth in vivo. Results: 20(S)-Rg3 downregulated 67 lncRNAs, and H19 was one of the most decreased lncRNAs. Suppression of H19 by siRNA transfection reduced glucose consumption, lactate production and PKM2 expression in ovarian cancer cells, while H19 overexpression in 20(S)-Rg3-treated ovarian cancer cells enhanced glucose consumption, lactate production and PKM2 expression. Dual-luciferase reporter assay and RIP results showed that H19 directly bound to miR-324-5p. Dual-luciferase reporter assay showed that miR-324-5p directly targeted PKM2, and miR-324-5p negatively regulated glucose consumption and lactate production in ovarian cancer cells. miR-324-5p overexpression inhibited cell proliferation in vitro and in vivo. Conclusion: Our study revealed that 20(S)-Rg3 blocked the competitive inhibition of H19 on miR-324-5p, which enhanced the suppression of miR-324-5p on PKM2 and therefore inhibited the Warburg effect and repressed tumorigenesis. In a word, 20(S)-Rg3 inhibited the Warburg effect in ovarian cancer cells via H19/miR-324-5p/PKM2 pathway.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>30481782</pmid><doi>10.1159/000495552</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1015-8987
ispartof Cellular physiology and biochemistry, 2018-01, Vol.51 (3), p.1340-1353
issn 1015-8987
1421-9778
language eng
recordid cdi_pubmed_primary_30481782
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Karger Open Access
subjects Animals
Antineoplastic Agents, Phytogenic - pharmacology
Antineoplastic Agents, Phytogenic - therapeutic use
Apoptosis
Bioinformatics
Breast cancer
Cancer therapies
Carrier Proteins - genetics
Cell culture
Cell growth
Cell Line, Tumor
Cell Proliferation - drug effects
Female
Gene expression
Gene Expression Regulation, Neoplastic - drug effects
Ginsenoside
Ginsenosides - pharmacology
Ginsenosides - therapeutic use
Glycolysis - drug effects
Humans
Immunoglobulins
Kinases
Long non-coding RNA
Medical prognosis
Membrane Proteins - genetics
Metabolism
Metastasis
Mice, Inbred BALB C
MicroRNAs
MicroRNAs - genetics
Original Paper
Ovarian cancer
Ovarian Neoplasms - drug therapy
Ovarian Neoplasms - genetics
Ovarian Neoplasms - metabolism
Ovarian Neoplasms - pathology
Ovary - drug effects
Ovary - metabolism
Ovary - pathology
Proteins
RNA, Long Noncoding - genetics
Thyroid Hormone-Binding Proteins
Thyroid Hormones - genetics
Warburg effect
title Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T13%3A45%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ginsenoside%2020(S)-Rg3%20Prevents%20PKM2-Targeting%20miR-324-5p%20from%20H19%20Sponging%20to%20Antagonize%20the%20Warburg%20Effect%20in%20Ovarian%20Cancer%20Cells&rft.jtitle=Cellular%20physiology%20and%20biochemistry&rft.au=Zheng,%20Xia&rft.date=2018-01-01&rft.volume=51&rft.issue=3&rft.spage=1340&rft.epage=1353&rft.pages=1340-1353&rft.issn=1015-8987&rft.eissn=1421-9778&rft_id=info:doi/10.1159/000495552&rft_dat=%3Cproquest_pubme%3E2301910543%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2301910543&rft_id=info:pmid/30481782&rft_doaj_id=oai_doaj_org_article_c8b7dddb2feb4f43956b946ae52568ba&rfr_iscdi=true